Michele Bortolini

806 total citations
10 papers, 644 citations indexed

About

Michele Bortolini is a scholar working on Surgery, Pharmacology and Oncology. According to data from OpenAlex, Michele Bortolini has authored 10 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Michele Bortolini's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Michele Bortolini is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Michele Bortolini collaborates with scholars based in Switzerland, United States and Italy. Michele Bortolini's co-authors include Alberto Corsini, Matthew B. Wright, Martin Bopst, Moh Tadayyon, C. Surrenti, F Fiaccadori, G Manzillo, C. Di Padova, M Frezza and Bogdana Balas and has published in prestigious journals such as Gastroenterology, The American Journal of Cardiology and Molecular Endocrinology.

In The Last Decade

Michele Bortolini

10 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Bortolini Switzerland 10 196 181 143 133 112 10 644
Dagmara Mohuczy United States 12 303 1.5× 203 1.1× 149 1.0× 213 1.6× 125 1.1× 17 913
Francis Heitz Switzerland 8 200 1.0× 207 1.1× 164 1.1× 60 0.5× 213 1.9× 8 855
Robert N. Schuck United States 17 162 0.8× 101 0.6× 64 0.4× 115 0.9× 47 0.4× 43 855
Karin Brecht Switzerland 15 399 2.0× 135 0.7× 200 1.4× 67 0.5× 93 0.8× 25 844
Xiaofei Fan China 15 223 1.1× 84 0.5× 76 0.5× 219 1.6× 98 0.9× 63 833
Amarjit S. Chaudhry United States 17 182 0.9× 308 1.7× 75 0.5× 62 0.5× 207 1.8× 20 737
Yi-Tsau Huang Taiwan 17 336 1.7× 260 1.4× 74 0.5× 290 2.2× 66 0.6× 22 964
Nancy Claude France 13 258 1.3× 87 0.5× 43 0.3× 90 0.7× 81 0.7× 18 541
Marina Del Puppo Italy 20 314 1.6× 44 0.2× 416 2.9× 172 1.3× 261 2.3× 54 929
Lihong Mao China 13 209 1.1× 76 0.4× 46 0.3× 176 1.3× 84 0.8× 32 658

Countries citing papers authored by Michele Bortolini

Since Specialization
Citations

This map shows the geographic impact of Michele Bortolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bortolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bortolini more than expected).

Fields of papers citing papers by Michele Bortolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bortolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bortolini. The network helps show where Michele Bortolini may publish in the future.

Co-authorship network of co-authors of Michele Bortolini

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bortolini. A scholar is included among the top collaborators of Michele Bortolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bortolini. Michele Bortolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yood, Marianne Ulcickas, Michele Bortolini, Deborah Casso, et al.. (2015). Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system. Pharmacoepidemiology and Drug Safety. 24(4). 427–434. 14 indexed citations
2.
Wright, Matthew B., Michele Bortolini, Moh Tadayyon, & Martin Bopst. (2014). Minireview: Challenges and Opportunities in Development of PPAR Agonists. Molecular Endocrinology. 28(11). 1756–1768. 131 indexed citations
3.
Corsini, Alberto & Michele Bortolini. (2013). Drug‐Induced Liver Injury: The Role of Drug Metabolism and Transport. The Journal of Clinical Pharmacology. 53(5). 463–474. 129 indexed citations
4.
Corsini, Alberto, Patricia E. Ganey, Cynthia Ju, et al.. (2012). Current Challenges and Controversies in Drug-Induced Liver Injury. Drug Safety. 35(12). 1099–1117. 36 indexed citations
5.
Bortolini, Michele, Matthew B. Wright, Martin Bopst, & Bogdana Balas. (2012). Examining the safety of PPAR agonists – current trends and future prospects. Expert Opinion on Drug Safety. 12(1). 65–79. 62 indexed citations
6.
Corsini, Alberto, Patricia E. Ganey, Cynthia Ju, et al.. (2012). Current Challenges and Controversies in Drug-Induced Liver Injury. Drug Safety. 35(12). 1099–1117. 36 indexed citations
7.
Farnier, Michel, Michele Bortolini, Thomas Salko, et al.. (2003). Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates ( bezafibrate , fenofibrate , or gemfibrozil ). The American Journal of Cardiology. 91(2). 238–240. 17 indexed citations
8.
Benghozi, Renée, Michele Bortolini, Yan Jia, et al.. (2002). Frequency of creatine kinase elevation during treatment with fluvastatin. The American Journal of Cardiology. 89(2). 231–233. 29 indexed citations
9.
Ballantyne, Christie M., Franco Pazzucconi, Xavier Pintó, et al.. (2001). Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Clinical Therapeutics. 23(2). 177–192. 65 indexed citations
10.
Frezza, M, C. Surrenti, G Manzillo, et al.. (1990). Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. Gastroenterology. 99(1). 211–215. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026